SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (1113)4/16/2002 12:48:22 AM
From: scaram(o)uche  Read Replies (1) of 2243
 
>> has a bunch of busted converts <<

One, due 2007.

But Peter's correct, Dave....... $180 million of it is the convert, and they may have to return $20M to Aventis.

>> Be interesting what their balance sheet would look like if they used some of the cash to repurchase part of the converts <<

Hmmmmmm........ nah. The new HCV molecule isn't to phase I yet. They need to cash.

edit.... sorry, I see that John had also answered.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News